Literature DB >> 34254279

CircRNA circ-ATAD1 Is Upregulated in Cervical Squamous Cell Carcinoma and Regulates Cell Proliferation and Apoptosis by Suppressing the Maturation of miR-218.

Zhiyi Fei1, Li Qin1, Fang Luo1, Yi Yu2.   

Abstract

The oncogenic function of circ-ATAD1 has been characterized in gastric cancer, while its role in cervical squamous cell carcinoma (CSCC) is unclear. This study explored the role of circ-ATAD1 in CSCC. To evaluate the differential expression of circ-ATAD1, mature miR-218, and premature miR-218 in CSCC, a total of 62 CSCC patients were subjected to biopsies to collect CSCC and paired normal tissues. Gene expression levels were quantified by RT-qPCRs. Nuclear fractionation assay was performed to analyze the subcellular location of circ-ATAD1. CSCC cells were used to perform cell transfections to explore the crosstalk between circ-ATAD1 and miR-218. The roles of circ-ATAD1 and miR-218 in CSCC cell behaviors were explored by BrdU assay, Transwell assay, cell apoptosis assay, and cell stemness assay. CSCC tissues exhibited upregulated expression of circ-ATAD1, which was localized to both nucleus and cytoplasm. Mature miR-218 was downregulated in CSCC tissues and was inversely correlated with circ-ATAD1, while premature miR-218 was not differentially expressed in CSCC. Upregulation of circ-ATAD1 in CSCC cells decreased the expression levels of mature miR-218, but not that of premature miR-218. In addition, overexpression of circ-ATAD1 increased cell proliferation and decreased cell apoptosis, while overexpression of miR-218 decreased cell proliferation and increased cell apoptosis, and it also attenuated the effects of overexpression of circ-ATAD1 on cell proliferation. However, CSCC cell invasion, migration, and stemness were not affected by circ-ATAD1 and miR-218. Circ-ATAD1 is upregulated in CSCC and may regulate cell proliferation and apoptosis by suppressing the maturation of miR-218.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Cervical squamous cell carcinoma; Circ-ATAD1; Proliferation; miR-218

Mesh:

Substances:

Year:  2021        PMID: 34254279     DOI: 10.1007/s43032-021-00661-9

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  13 in total

Review 1.  Immunotherapy and targeted therapy for cervical cancer: an update.

Authors:  Gulden Menderes; Jonathan Black; Carlton L Schwab; Alessandro D Santin
Journal:  Expert Rev Anticancer Ther       Date:  2015-12-07       Impact factor: 4.512

Review 2.  Systemic therapy in cervical cancer: 30 years in review.

Authors:  Michalis Liontos; Anastasios Kyriazoglou; Ioannis Dimitriadis; Meletios-Athanasios Dimopoulos; Aristotelis Bamias
Journal:  Crit Rev Oncol Hematol       Date:  2019-02-28       Impact factor: 6.312

Review 3.  Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer.

Authors:  Sarah M Crafton; Ritu Salani
Journal:  Clin Ther       Date:  2016-02-28       Impact factor: 3.393

Review 4.  Cervical cancer: A global health crisis.

Authors:  William Small; Monica A Bacon; Amishi Bajaj; Linus T Chuang; Brandon J Fisher; Matthew M Harkenrider; Anuja Jhingran; Henry C Kitchener; Linda R Mileshkin; Akila N Viswanathan; David K Gaffney
Journal:  Cancer       Date:  2017-05-02       Impact factor: 6.860

Review 5.  Molecular targeted therapy: Treating cancer with specificity.

Authors:  Yeuan Ting Lee; Yi Jer Tan; Chern Ein Oon
Journal:  Eur J Pharmacol       Date:  2018-07-20       Impact factor: 4.432

Review 6.  Epidemiology and Early Detection of Cervical Cancer.

Authors:  Peter Hillemanns; Phillip Soergel; Hermann Hertel; Matthias Jentschke
Journal:  Oncol Res Treat       Date:  2016-08-22       Impact factor: 2.825

Review 7.  circRNAs in Cancer.

Authors:  Ines Lucia Patop; Sebastian Kadener
Journal:  Curr Opin Genet Dev       Date:  2017-12-12       Impact factor: 5.578

8.  MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-κB signaling pathway.

Authors:  Yunsheng Xu; Qin He; Yiyi Lu; Fengxing Tao; Liang Zhao; Rongying Ou
Journal:  Cancer Cell Int       Date:  2018-12-04       Impact factor: 5.722

9.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.

Authors:  Marc Arbyn; Elisabete Weiderpass; Laia Bruni; Silvia de Sanjosé; Mona Saraiya; Jacques Ferlay; Freddie Bray
Journal:  Lancet Glob Health       Date:  2019-12-04       Impact factor: 26.763

10.  Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.

Authors:  Noriko Yamamoto; Takashi Kinoshita; Nijiro Nohata; Toshihiko Itesako; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Naohiko Seki
Journal:  Int J Oncol       Date:  2013-03-07       Impact factor: 5.650

View more
  2 in total

Review 1.  Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity.

Authors:  Yuanyuan Zhang; Zhichen Tian; Haibo Ye; Xiaomei Sun; Huiming Zhang; Yujia Sun; Yongjiang Mao; Zhangping Yang; Mingxun Li
Journal:  Cell Death Discov       Date:  2022-05-20

2.  Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.

Authors:  Chunhua He; Leng Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.